Eagle Global Advisors LLC purchased a new position in shares of Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 62,326 shares of the company's stock, valued at approximately $590,000. Eagle Global Advisors LLC owned approximately 0.33% of Brainsway at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Lazard Asset Management LLC acquired a new stake in shares of Brainsway in the 4th quarter valued at $44,000. GAMMA Investing LLC boosted its holdings in shares of Brainsway by 720.7% in the 1st quarter. GAMMA Investing LLC now owns 9,356 shares of the company's stock valued at $89,000 after purchasing an additional 8,216 shares in the last quarter. Palumbo Wealth Management LLC acquired a new stake in shares of Brainsway in the 1st quarter valued at $111,000. Cubist Systematic Strategies LLC boosted its holdings in shares of Brainsway by 14.6% in the 4th quarter. Cubist Systematic Strategies LLC now owns 19,228 shares of the company's stock valued at $181,000 after purchasing an additional 2,446 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Brainsway by 61.9% in the 4th quarter. JPMorgan Chase & Co. now owns 23,918 shares of the company's stock valued at $226,000 after purchasing an additional 9,149 shares in the last quarter. Institutional investors and hedge funds own 30.11% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on BWAY. HC Wainwright reaffirmed a "buy" rating and set a $17.00 target price (up from $16.00) on shares of Brainsway in a research report on Thursday. Wall Street Zen lowered Brainsway from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Northland Securities raised their target price on Brainsway from $15.00 to $19.00 and gave the stock an "outperform" rating in a research report on Thursday.
View Our Latest Stock Report on BWAY
Brainsway Price Performance
Shares of NASDAQ:BWAY traded up $0.15 during trading on Friday, hitting $12.98. 67,865 shares of the company were exchanged, compared to its average volume of 48,563. The company has a market cap of $245.30 million, a PE ratio of 49.92 and a beta of 1.42. The stock has a 50 day moving average of $12.08 and a 200 day moving average of $10.53. Brainsway Ltd. Sponsored ADR has a 52-week low of $7.06 and a 52-week high of $13.65.
Brainsway (NASDAQ:BWAY - Get Free Report) last posted its earnings results on Wednesday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.03. The firm had revenue of $12.63 million for the quarter, compared to the consensus estimate of $12.34 million. Brainsway had a return on equity of 8.97% and a net margin of 11.60%. Sell-side analysts forecast that Brainsway Ltd. Sponsored ADR will post 0.08 EPS for the current fiscal year.
Brainsway Company Profile
(
Free Report)
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.
Read More
Before you consider Brainsway, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brainsway wasn't on the list.
While Brainsway currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access